Transcriptomics

Dataset Information

0

Type 2 Innate Lymphoid Cells Treat and Prevent GI Tract GvHD Through Enhanced Accumulation of Myeloid Derived Suppressor Cells

ABSTRACT: Transcriptome analysis of in vitro expanded murine type 2 innate lymphoid cells

ORGANISM(S): Mus musculus

PROVIDER: GSE95811 | GEO | 2017/03/15

SECONDARY ACCESSION(S): PRJNA378499

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD.
| S-EPMC8759141 | biostudies-literature
Unknown Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.
| S-EPMC5409787 | biostudies-literature
Unknown Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.
| S-EPMC9221132 | biostudies-literature
Unknown Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation.
| S-EPMC6246030 | biostudies-literature
Unknown Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.
| S-EPMC7033370 | biostudies-literature
Unknown Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.
| S-EPMC5490758 | biostudies-literature
Unknown A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
| S-EPMC10195122 | biostudies-literature
Unknown Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.
| S-EPMC9092418 | biostudies-literature
Unknown Acute GVHD: think before you treat.
| S-EPMC8791180 | biostudies-literature
Unknown A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.
| S-EPMC10163318 | biostudies-literature